Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. March 25, 2019. R. Kevin Plemmons.

Executive Summary

Innovative Cardiovascular Solutions hopes to earn the CE mark and US FDA approval for its Emblok Embolic Protection System. See what the company's CEO, R. Kevin Plemmons, said about the technology here.

“By effectively protecting the brachiocephalic artery, we can protect the entire body – not only the critical three cerebral arteries -- but downstream as well to the abdominal and peripheral vasculature." –R. Kevin Plemmons, CEO, Innovative Cardiovascular Solutions

Click here for a free trial of Medtech Insight

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts